NO20024679L - Crystalline Pharmaceuticals - Google Patents

Crystalline Pharmaceuticals

Info

Publication number
NO20024679L
NO20024679L NO20024679A NO20024679A NO20024679L NO 20024679 L NO20024679 L NO 20024679L NO 20024679 A NO20024679 A NO 20024679A NO 20024679 A NO20024679 A NO 20024679A NO 20024679 L NO20024679 L NO 20024679L
Authority
NO
Norway
Prior art keywords
pharmaceuticals
crystalline
crystalline pharmaceuticals
Prior art date
Application number
NO20024679A
Other languages
Norwegian (no)
Other versions
NO20024679D0 (en
NO325005B1 (en
Inventor
Daniel A Dickman
Sanjay Chemburkar
James J Fort
Rodger F Henry
David Lechuga-Ballesteros
Yuping Niu
William Porter
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27065762&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20024679(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/793,536 external-priority patent/US6608198B2/en
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20024679D0 publication Critical patent/NO20024679D0/en
Publication of NO20024679L publication Critical patent/NO20024679L/en
Publication of NO325005B1 publication Critical patent/NO325005B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20024679A 2000-03-30 2002-09-30 Crystalline forms of lopinavir, pharmaceutical compositions comprising these and their use NO325005B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53825700A 2000-03-30 2000-03-30
US09/793,536 US6608198B2 (en) 2000-03-30 2001-02-27 Crystalline pharmaceutical
PCT/US2001/009112 WO2001074787A2 (en) 2000-03-30 2001-03-21 Crystalline pharmaceutical

Publications (3)

Publication Number Publication Date
NO20024679D0 NO20024679D0 (en) 2002-09-30
NO20024679L true NO20024679L (en) 2002-09-30
NO325005B1 NO325005B1 (en) 2008-01-14

Family

ID=27065762

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024679A NO325005B1 (en) 2000-03-30 2002-09-30 Crystalline forms of lopinavir, pharmaceutical compositions comprising these and their use

Country Status (22)

Country Link
EP (1) EP1268442A2 (en)
JP (1) JP2003529592A (en)
KR (1) KR100773258B1 (en)
CN (2) CN1330639C (en)
AR (2) AR033360A1 (en)
AU (3) AU2001250920B2 (en)
BG (1) BG107165A (en)
BR (1) BR0109433A (en)
CA (1) CA2403635A1 (en)
CZ (1) CZ20023529A3 (en)
HU (1) HUP0302675A3 (en)
IL (1) IL151551A0 (en)
MX (1) MXPA02009559A (en)
MY (1) MY128296A (en)
NO (1) NO325005B1 (en)
NZ (1) NZ521183A (en)
PE (1) PE20011232A1 (en)
PL (1) PL359727A1 (en)
SA (2) SA01220270B1 (en)
SK (1) SK14832002A3 (en)
TW (1) TWI284640B (en)
WO (1) WO2001074787A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608198B2 (en) 2000-03-30 2003-08-19 Abbott Laboratories Crystalline pharmaceutical
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8445506B2 (en) 2009-02-06 2013-05-21 Hetero Research Foundation Polymorphs of lopinavir
CN102470158A (en) * 2009-08-27 2012-05-23 默沙东公司 Processes for preparing protease inhibitors of hepatitis c virus
CN112830899A (en) * 2021-01-18 2021-05-25 合肥华方医药科技有限公司 Novel lopinavir crystal form and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914332A (en) 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
AU8145198A (en) * 1997-06-16 1999-01-04 Vertex Pharmaceuticals Incorporated Methods of increasing the bioavailability of stable crystal polymorphs of a compound

Also Published As

Publication number Publication date
KR20030011807A (en) 2003-02-11
SA06270303B1 (en) 2009-08-02
CN101066952A (en) 2007-11-07
PE20011232A1 (en) 2001-12-08
MXPA02009559A (en) 2003-05-21
CN1330639C (en) 2007-08-08
JP2003529592A (en) 2003-10-07
WO2001074787A2 (en) 2001-10-11
NO20024679D0 (en) 2002-09-30
HUP0302675A3 (en) 2004-03-29
MY128296A (en) 2007-01-31
CA2403635A1 (en) 2001-10-11
CZ20023529A3 (en) 2003-02-12
NO325005B1 (en) 2008-01-14
AR033360A1 (en) 2003-12-17
NZ521183A (en) 2004-03-26
IL151551A0 (en) 2003-04-10
TWI284640B (en) 2007-08-01
KR100773258B1 (en) 2007-11-05
AU2001250920B2 (en) 2006-06-29
HUP0302675A2 (en) 2003-12-29
BG107165A (en) 2003-07-31
BR0109433A (en) 2004-08-10
AU2006222711A1 (en) 2006-10-19
AR049560A2 (en) 2006-08-16
PL359727A1 (en) 2004-09-06
AU5092001A (en) 2001-10-15
CN1422259A (en) 2003-06-04
SK14832002A3 (en) 2003-02-04
SA01220270B1 (en) 2006-11-14
EP1268442A2 (en) 2003-01-02
WO2001074787A3 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
NO20003967D0 (en) Pharmaceuticals
NO20026196L (en) Kinazolinditosylatsalt compounds
DK1226127T3 (en) Substituted phenylsulfamoylcarboxamides
DK1619192T3 (en) Aryl-condensed azapolycyclic compounds
DK1255740T3 (en) Substituted arylpyrazines
AR028393A1 (en) SUBSTITUTED IMINOAZIDS
NO20020030L (en) Crystalline 1-methylcarbapenem compounds
DK1331972T3 (en) Pharmaceuticals
AR028302A1 (en) SUBSTITUTED FENILURACILOS
IT250181Y1 (en) IMPROVED CASE FOR RIVOLELLA
DE60130137D1 (en) CRYSTALLIZATION PROCESS
DE50112662D1 (en) SUBSTITUTED BENZOYLCYCLOHEXENONE
ATE372338T1 (en) DESHALOGEN COMPOUNDS
NO20030303L (en) Calcilitic compounds
NO20023508L (en) Calcilitic compounds
NO20031837D0 (en) Calcilitic compounds
NO20024679L (en) Crystalline Pharmaceuticals
EE200300045A (en) Crystalline drug substance
DE29905913U1 (en) Wrench
DE29900615U1 (en) Wrench
SE0001187D0 (en) Crystalline form
SE0001422D0 (en) Crystalline form
DE29904045U1 (en) Improved wrench
DE29905008U1 (en) Wrench
SE9904417D0 (en) Crystalline form

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application